Skip to main content

Increasingly sophisticated technologies such as NGS panels, exomes, whole genomes and microarrays are being introduced in routine testing in both clinical genetics and molecular pathology. Lab managers face the challenge to efficiently implement these novel technologies in their routine workflow, reaching fast turnaround times while at the same time ensuring variant assessment and reporting happens at the highest possible clinical standards.

Cartagenia Bench Lab for Clinical Genetics

Clinical-grade variant assessment and reporting for inherited diseases

Cartagenia Bench Lab for Molecular Pathology

Clinical-grade somatic variant assessment and reporting

Cartagenia Bench Lab is marketed in the USA as an exempt Class I Medical Device and in Europe and Canada as a Class I medical device.